Mads Hald Andersen

Mads Hald Andersen

Clinical Professor

Member of:

    ORCID: 0000-0002-2914-9605

    Publication year:
    All
    1 - 10 out of 13Page size: 10
    Sort by: 1st author
    1. Submitted

      IkB based Immunotherapy

      Andersen, Mads Hald, 2011, (Submitted) 26 Oct 2011

      Research output: Patent

    2. Submitted

      PD-L1 based Immunotherapy

      Andersen, Mads Hald, 17 Oct 2011, (Submitted) 17 Oct 2011

      Research output: Patent

    3. Published

      Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors

      Andersen, R. S., Sørensen, R. B., Ritter, C., Svane, Inge Marie, Becker, J. C., thor Straten, P. & Andersen, Mads Hald, 2011, In: Cancer Immunology, Immunotherapy. 60, 2, p. 227-34 8 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Published

      Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2

      Bjoern, J., Brimnes, M. K., Andersen, Mads Hald, Straten, P. T. & Svane, Inge Marie, 2011, In: Scandinavian Journal of Immunology. 73, 3, p. 222-33 12 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. Published

      Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial

      Jensen, J. U., Hein, L., Lundgren, B., Bestle, M. H., Mohr, T. T., Andersen, M. H., Thornberg, K. J., Løken, J., Steensen, M., Fox, Z., Tousi, H., Søe-Jensen, P., Lauritsen, A. Ø., Strange, D., Petersen, P. L., Reiter, N., Hestad, S., Thormar, K., Fjeldborg, P., Larsen, K. M. & 6 others, Drenck, N. E., Ostergaard, C., Kjær, J., Grarup, J., Lundgren, Jens & Procalcitonin And Survival Study (PASS) Group, P. A. S. S. (. G., 1 Sep 2011, In: Critical Care Medicine. 39, 9, p. 2048-58 11 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    6. Published

      Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application

      Junker, N., Thor Straten, P., Andersen, Mads Hald & Svane, Inge Marie, 2011, In: Journal of Skin Cancer. 2011, 574695, 6 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    7. Published

      Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer

      Junker, N., Andersen, Mads Hald, Wenandy, L., Dombernowsky, S. L., Kiss, K., Sørensen, C. H., Therkildsen, M. H., Buchwald, C. V., Andersen, E., Straten, P. T., Svane, Inge Marie & Andersen, Mads Hald, 24 Mar 2011, In: Cytotherapy. 13, 7, p. 822-34

      Research output: Contribution to journal › Journal article › Research › peer-review

    8. Published

      Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer

      Junker, N., Andersen, Mads Hald, Wenandy, L., Dombernowsky, S. L., Kiss, K., Sørensen, C. H., Therkildsen, M. H., von Buchwald, Christian, Andersen, E., Straten, P. T. & Svane, Inge Marie, 2011, In: Cytotherapy. 13, 7, p. 822-34 13 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    9. Published

      HLA-A2-restricted survivin-derived T-cell responses

      Straten, P. T. & Andersen, Mads Hald, 2011, In: Vaccine. 29, 52, p. 9582

      Research output: Contribution to journal › Letter › Research › peer-review

    10. Published

      Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination

      Straten, P. T. & Andersen, Mads Hald, 12 May 2011, In: Vaccine. 29, 21, p. 3728

      Research output: Contribution to journal › Journal article › Research › peer-review

    Previous 1 2 Next

    ID: 13571778